Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
LHLabcorp
FinDog View：Neutral
| Metric | CVS | LH |
|---|
| Close | 91.72 | 324.51 |
| Market Cap | $117B | $26.3B |
| 1M | −2.44% | +0.36% |
| P/E (TTM) | 24.4 | 26.3 |
| Forward P/E | 13.2 | 16.7 |
| P/E 5-Yr Percentile | 65 | 28 |
| P/S | 0.3 | 1.8 |
| P/B | 1.5 | 3.1 |
| Dividend Yield | 3.49% | 1.35% |
| Latest Quarter Revenue | $106B | $3.7B |
| Revenue YoY | +7.3% | +5.8% |
| Gross Margin | 44.5% | 29.8% |
| Latest Quarter EPS | 2.31 | 3.64 |
| Avg Post-Earnings Move | ±2.3% | ±1.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 3.58% |
| 90-Day Net Insider Buying | — | −$3.3M |
CVS · Revenue, Last 8 Quarters ($B)
LH · Revenue, Last 8 Quarters ($B)
